Predicting psoriasis using routine laboratory tests with random forest.
Adolescent
Adult
Age Distribution
Aged
Aged, 80 and over
Algorithms
Biomarkers
/ metabolism
Case-Control Studies
Child
Child, Preschool
Cholesterol
/ metabolism
Cholesterol, HDL
/ metabolism
Diagnostic Tests, Routine
Female
Humans
Infant
Machine Learning
Male
Middle Aged
Psoriasis
/ diagnosis
Quality of Life
Serum Albumin, Human
/ metabolism
Young Adult
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
06
12
2020
accepted:
05
10
2021
entrez:
19
10
2021
pubmed:
20
10
2021
medline:
25
11
2021
Statut:
epublish
Résumé
Psoriasis is a chronic inflammatory skin disease that affects approximately 125 million people worldwide. It has significant impacts on both physical and emotional health-related quality of life comparable to other major illnesses. Accurately prediction of psoriasis using biomarkers from routine laboratory tests has important practical values. Our goal is to derive a powerful predictive model for psoriasis disease based on only routine hospital tests. We collected a data set including 466 psoriasis patients and 520 healthy controls with 81 variables from only laboratory routine tests, such as age, total cholesterol, HDL cholesterol, blood pressure, albumin, and platelet distribution width. In this study, Boruta feature selection method was applied to select the most relevant features, with which a Random Forest model was constructed. The model was tested with 30 repetitions of 10-fold cross-validation. Our classification model yielded an average accuracy of 86.9%. 26 notable features were selected by Boruta, among which 15 features are confirmed from previous studies, and the rest are worth further investigations. The experimental results demonstrate that the machine learning approach has good potential in predictive modeling for the psoriasis disease given the information only from routine hospital tests.
Identifiants
pubmed: 34665828
doi: 10.1371/journal.pone.0258768
pii: PONE-D-20-35896
pmc: PMC8525763
doi:
Substances chimiques
Biomarkers
0
Cholesterol, HDL
0
Cholesterol
97C5T2UQ7J
Serum Albumin, Human
ZIF514RVZR
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0258768Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Arch Dermatol Res. 2006 Dec;298(7):321-8
pubmed: 17021763
J Clin Diagn Res. 2017 Sep;11(9):EC13-EC16
pubmed: 29207715
Am J Clin Dermatol. 2012 Feb 1;13(1):37-47
pubmed: 21888450
Acta Dermatovenerol Alp Pannonica Adriat. 2017 Dec;26(4):97-100
pubmed: 29264899
Indian Dermatol Online J. 2015 Mar-Apr;6(2):81-3
pubmed: 25821726
Pak J Biol Sci. 2013 Mar 15;16(6):291-4
pubmed: 24498793
Angiology. 2017 Mar;68(3):266-270
pubmed: 27401209
Front Immunol. 2014 Aug 12;5:368
pubmed: 25161652
Yonsei Med J. 2015 May;56(3):712-8
pubmed: 25837177
Rev Assoc Med Bras (1992). 2018 Apr;64(4):368-373
pubmed: 30133617
Br J Dermatol. 2007 Jul;157(1):68-73
pubmed: 17553036
Int J Dermatol. 1993 Aug;32(8):582-6
pubmed: 8407074
J Autoimmun. 2015 Nov;64:66-73
pubmed: 26215033
Int J Inflam. 2017;2017:5217687
pubmed: 28421157
Circulation. 2012 Apr 17;125(15):1905-19
pubmed: 22508840
Clin Exp Dermatol. 2017 Mar;42(2):131-136
pubmed: 28044372
Br J Dermatol. 2019 Jan;180(1):94-99
pubmed: 29904911
Br J Dermatol. 2004 Feb;150(2):232-44
pubmed: 14996093
Bioinformatics. 2012 Sep 15;28(18):i370-i374
pubmed: 22962454
J Med Eng Technol. 2009;33(7):516-24
pubmed: 19639508
Clin Transl Med. 2015 Mar 19;4:13
pubmed: 25883770
Bioinformatics. 2007 Jun 1;23(11):1309-12
pubmed: 17308343
J Clin Invest. 1999 Jan;103(2):219-27
pubmed: 9916134
Am J Med. 2014 Dec;127(12):1148-53
pubmed: 25149424
J Biol Chem. 2005 Jun 24;280(25):24159-67
pubmed: 15855153